Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: Evaluation of predictive factors

Gut

Volumn 38, Issue 4, 1996, Pages 578-581

  Giardiello, F M ^a,c   Offerhaus, J A ^b   Tersmette, A C ^b   Hylind, L M ^a   Krush, A J ^a   Brensinger, J D ^a   Booker, S V ^a   Hamilton, S R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Colorectal adenomas; Familial adenomatous polyposis; Sulindac

Indexed keywords

SULINDAC;

ADENOMA; ADOLESCENT; ADULT; ANASTOMOSIS; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FAMILIAL POLYPOSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0029964295     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.4.578     Document Type: Article

References (22)

1. Nonsteroidal anti-inflammatory agents. In: Mc Evoy G, ed. AHFS Drug Information. Bethesda MD: the American Society of Hospital Pharmacists, 1993: 1201-5.
2. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983; 24: 83-7.
3. Kinzler KW, Nilbert MC, Su LK, Vogelstein K, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-5.
4. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
5. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bones C, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 635-4.
6. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 398: 1313-6.
7. Nugent KP, Farmer KCR, Spigelman AD, Williams DB, Phillips RKS. Randomized controlled clinical trial of sulindac on intestinal polyposis in FAP. Br J Surg 1995; 80: 1618-9.
8. Ahnen D, Alberts D, Hixson L, Paranka X, Burt R, Panukcu R. The sulfone metabolite of sulindac (FGN-1) inhibits rat colonic carcinogenesis but does not inhibit either prostaglandin synthesis or colonie proliferation. Gastroenterology 1995; 108: A444.
9. Nagase H, Miyoshi Y, Horii A, Aoki T, Ogawa M, Utsonomiya J, et al. Germ-line mutations of the APC gene in patients with familial adenomatous polyposis: screening of 150 unrelated patients. Am J Hum Genet 1992; 51: A39.
10. Powell SM, Petersen GM, Krush AJ, Booker SV, Jen J, Giardiello FM, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982-7.
11. Miyoshi V, Ando H, Nagase H, Nishisho I, Horii A, Niki Y, et al. Germ-line mutations of the APC gene in 55 familial adenomatous polyposis patients. Proc. Natl Acad Sci 1992; 89: 4452-6.
12. Hucker HB, Stauffer SC, White SD, Rhodes RE, Arison BH, Umbenhauer ER, et al. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-r-Fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl]-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metabolism and Disposition 1973; 1: 721-36.
13. Duggan DE, Hooke KF, Risley EA, Shen TY, Van Arman CG. Identification of the biologically active form of sulindac. J Pharmacol Exp Ther 1977; 201: 8-13.
14. Hixson LJ, Alberts DS, Kruztsch M, Einsphar J, Brendel K, Gross PH, et al. Antiproliferative effect of nonsteroidal antiinflammatory drugs against human cancer cells. Cancer Epidemiol Biomarkers Prev 1994; 5: 433-8.
15. Ahnen D, Piazza G, Alberts D, Paranka N, Burt R, Pamukcu R. Sulindac sultide and sulfone both inhibit the growth of colon cancer cell lines by inducing apoptosis. Gastroenterology 1995; 108: A443.
16. Shen TY, Winter CA. Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res 1977; 12: 89-245.
17. Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V, et al. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal antiinflammatory agent. Cancer Res 1995; 55: 1464-72.
18. Farmer KCR, Phillips RKS. Colectomy and ileorectal anastomosis lowers rectal mucosal proliferation. Dis Colon Rectum 1993; 36: 167.
19. Pasricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar AJ, Zahurak ML, et al. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 1995; 109: 994-8.
20. Debinski HS, Trojan J, Nugent KP, Spigelman AD, Phillips RKS. Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet 1995; 345: 855-6.
21. Niv Y, Fraser GM. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy Gastroenterology 1994; 107: 854-7.
22. Thorson AG, Lynch HT, Smyrk TC. Rectal cancer in FAP patient after sulindac. Lancet 1994; 343: 180.